Gene · 5550
Papers2,494
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,494
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of DPP-IV inhibitory peptides derived from buffalo colostrum: Mining through bioinformatics, in silico and in vitro approaches. | J Mol Recognit | 2024 | 38803118 | PubTator, text mining | PubMed |
| Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned. | J Med Chem | 2024 | 38783480 | PubTator, text mining | PubMed |
| Is aromatic plants environmental health engineering (APEHE) a leverage point of the earth system? | Heliyon | 2024 | 38756557 | PubTator, text mining | PubMed |
| Angiotensin-(1-12): Does It Exist? A Critical Evaluation in Humans, Rats, and Mice. | Hypertension | 2024 | 38716648 | PubTator, text mining | PubMed |
| Bacteria lose a pep in their step. | Nat Chem Biol | 2024 | 38671224 | PubTator, text mining | PubMed |
| Protein Hydrolysis as a Way to Valorise Squid-Processing Byproducts: Obtaining and Identification of ACE, DPP-IV and PEP Inhibitory Peptides. | Mar Drugs | 2024 | 38667773 | PubTator, text mining | PubMed |
| Discovery of a Tunable Heterocyclic Electrophile 4-Chloro-pyrazolopyridine That Defines a Unique Subset of Ligandable Cysteines. | ACS Chem Biol | 2024 | 38629450 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular mechanisms underlying chloroplast biogenesis in albino Agave angustifolia plantlets. | Physiol Plant | 2024 | 38606618 | PubTator, text mining | PubMed |
| Improvement of catalysis performance of pepsin and lipase enzymes by double enzyme immobilization method. | RSC Adv | 2024 | 38590345 | PubTator, text mining | PubMed |
| Preliminary development of a measure of parental behavioral responses to everyday pains in young children: the PREP. | Pain Rep | 2024 | 38586593 | PubTator, text mining | PubMed |
| Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action. | ACS Chem Biol | 2024 | 38567529 | PubTator, text mining | PubMed |
| Exploring bi-carbazole-linked triazoles as inhibitors of prolyl endo peptidase via integrated in vitro and in silico study. | Sci Rep | 2024 | 38561470 | PubTator, text mining | PubMed |
| 5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions. | J Med Chem | 2024 | 38546708 | PubTator, text mining | PubMed |
| Lower revascularization rates after high-speed rotational atherectomy compared to modified balloons in calcified coronary lesions: 5-year outcomes of the randomized PREPARE-CALC trial. | Clin Res Cardiol | 2024 | 38483633 | PubTator, text mining | PubMed |
| The interpreter's role and deaf students' autonomy in mainstream classrooms. | J Deaf Stud Deaf Educ | 2024 | 38483329 | PubTator, text mining | PubMed |
| It is theoretically possible to avoid misfolding into non-covalent lasso entanglements using small molecule drugs. | PLoS Comput Biol | 2024 | 38470915 | PubTator, text mining | PubMed |
| Generation Pep - study protocol for an intersectoral community-wide physical activity and healthy eating habits initiative for children and young people in Sweden. | Front Public Health | 2024 | 38435288 | PubTator, text mining | PubMed |
| Numerical investigation on the influence of nonuniform tip clearance on rotor tip-clearance flow field structure. | Heliyon | 2024 | 38333843 | PubTator, text mining | PubMed |
| ACE inhibitors and their interaction with systems and molecules involved in metabolism. | Heliyon | 2024 | 38298628 | PubTator, text mining | PubMed |
| Production of the prolyl endoprotease (PEP) from Aspergillus sp. FSDE 16 by solid-state fermentation (SSF) and use for producing a gluten-free beer. | Biotechnol Appl Biochem | 2024 | 38212282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5550/papers?page=6